BASELINE AND EARLY PREDICTORS OF RESPONSE TO RISANKIZUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

Jean-Frédéric Colombel  1     Walter Reinisch  2     Stefan Schreiber  3     Silvio Danese  4     Ken Sugimoto  5     Maria T. Abreu  6     Naomi Martin  7     Kristina Kligys  7     Valerie Pivorunas  7     Alexandra Song  7     Javier Zambrano  7     Yafei Zhang  7     Remo Panaccione  8    
1 Icahn School of Medicine at Mount Sinai, USA, United States
2 Medical University of Vienna, Wien, Austria
3 University Hospital Schleswig-Holstein, Kiel, Germany
4 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
5 Hamamatsu University School of Medicine, Hamamatsu, Japan
6 University of Miami, Miller School of Medicine, Miami, United States
7 AbbVie Inc., North Chicago, United States
8 University of Calgary, Calgary, Canada

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing